Anib (Afatinib) 40mg Tablets | DIL Bangladesh Generic | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

Share
Product description

Generic Information: Anib (Afatinib) — DIL, Bangladesh

Anib is a generic afatinib produced by Drug International Limited (DIL), a well-known pharmaceutical manufacturer based in Bangladesh. Supplied as 40 mg film-coated tablets in a 30-tablet pack, Anib provides an economical route to second-generation EGFR-targeted therapy for patients with EGFR-mutant non-small cell lung cancer. DIL has a long track record in producing oncology generics that meet international quality standards, making Anib a dependable lower-cost alternative to the originator brand.

What Is Anib (Afatinib) Used For?

Anib is indicated for the treatment of non-small cell lung cancer with activating EGFR mutations, including the common exon 19 deletions and L858R substitution, and the less common G719X, L861Q and S768I mutations. It serves as a first-line therapy for EGFR-mutant NSCLC and is also used in metastatic squamous NSCLC that has progressed after platinum-based chemotherapy.

How Does Anib (Afatinib) Work?

Anib contains afatinib, an irreversible pan-ErbB tyrosine kinase inhibitor. It forms a permanent covalent bond with the kinase domains of EGFR, HER2 and ErbB4, blocking the signaling pathways that drive the growth and survival of EGFR-mutant lung cancer cells. This irreversible blockade provides durable tumor control and distinguishes afatinib from reversible first-generation EGFR inhibitors.

Indications

Anib is indicated for adults with locally advanced or metastatic non-small cell lung cancer whose tumors have non-resistant EGFR mutations, and for metastatic squamous NSCLC progressing after platinum-based therapy. EGFR mutation testing must confirm eligibility before treatment.

Dosage

The standard dose is 40 mg once daily, taken at least one hour before or two hours after a meal. The 30-tablet pack provides approximately one month of therapy. A lower 30 mg dose may be used for patients with severe renal impairment or to manage tolerability, always under oncologist supervision.

Side Effects

Common side effects of Anib include diarrhea, acneiform rash, stomatitis, paronychia, dry skin and decreased appetite. Serious adverse reactions such as interstitial lung disease, hepatotoxicity and severe skin reactions occur rarely but require immediate medical attention. Proactive management of diarrhea and skin toxicity is recommended.

Storage

Store Anib in a cool, dry place away from sunlight and moisture, in the original packaging. Keep out of reach of children and take tablets whole with water.

Why Choose the GLT?

Anib through GLT offers the DIL afatinib generic at a cost that makes long-term EGFR-targeted therapy far more accessible, without sacrificing the trusted 40 mg dose or once-daily convenience. We source genuine, correctly stored stock and supply the documentation needed for informed cross-border purchasing. For patients seeking an affordable, quality-assured afatinib, Anib is a strong, practical choice.

How to Order Anib (Afatinib)

To place an order, contact us on WhatsApp at +86 15234153837 or by email at [email protected]. Share your required quantity and destination, and we will confirm availability, pricing and shipping.

FAQ

Who makes Anib? Anib is manufactured by Drug International Limited (DIL), a pharmaceutical company based in Bangladesh.

Is Anib equivalent to Gilotrif? Anib is a generic afatinib containing the same 40 mg active ingredient, used for the same EGFR-mutant NSCLC indications as the originator Gilotrif.

How many tablets are in a pack? This listing covers the 40 mg, 30-tablet pack, which is about one month of once-daily dosing.

Do I need a prescription? Yes, afatinib is a prescription medicine and should be taken under a physician's supervision.

Related Oncology Products

Orforglipron (LuciOrfor) 0.8–17.2mg Tablets | Laos Generic Oral GLP-1 | GLT

Lucius Pharmaceuticals (Laos) generic orforglipron, 6-dose titration for weight management

XinKePing 欣可平 (Avatrombopag) 20mg*10 Tablets | Nanjing Hencer China | GLT

XinKePing — API-plus-tablet integrated avatrombopag from Nanjing Hencer Pharmaceutical (Jemcare group), China Mainland

Tixepa (Tirzepatide) 20mg/2mL & 30mg/2mL Multi-Dose Pen | Drug International | GLT

Tixepa — Drug International Limited (DIL) tirzepatide multi-dose pen, two official strengths (Tixepa-5 = 20mg/2mL,...

Barinib (Baricitinib) 2mg | Generic JAK1/JAK2 Inhibitor | Drug International Limited | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Drug International Limited (Bangladesh) — an affordable alternative to Olumiant...

LuciAvat (Avatrombopag) 20mg*28 Tablets | Lucius Pharmaceuticals Laos | GLT

LuciAvat — avatrombopag 20mg (23.6mg maleate) film-coated tablets by Lucius Pharmaceuticals (Lao) Co., Ltd., Vientiane

Zepbound (Tirzepatide) 2.5–15mg/0.5mL Single-Dose Pen | Eli Lilly USA | GLT

Zepbound — Eli Lilly tirzepatide single-dose pen, six US strengths (2.5–15mg/0.5mL) for chronic weight management...

KeZeRui 科瑞泽 (Avatrombopag) 20mg*10 Tablets | Sichuan Kelun China | GLT

KeZeRui — national-procurement avatrombopag from Sichuan Kelun Pharmaceutical, China's integrated API + tablet maker

Baricent (Baricitinib) 2mg | Generic JAK1/JAK2 Inhibitor | Incepta Pharmaceuticals Ltd. | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Incepta Pharmaceuticals Ltd. (Bangladesh) — an affordable alternative to Olumiant...